drugset / Trial / NCT04395365
Primary Antibiotic Prophylaxis Using Co-trimoxazole to Prevent Spontaneous Bacterial Peritonitis in Cirrhosis
Phase 3
Unknown
442 enrolled
University College, London
National Institute for Health Research, United Kingdom · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
A multicentre, interventional, double-blind, placebo-controlled, parallel-arm, phase 3, randomised controlled trial to evaluate the use of co-trimoxazole as primary prophylaxis for spontaneous bacterial peritonitis to improve overall survival
Timeline
- Start
- 2019-06-30
- Primary completion
- 2025-10
- Completion
- 2025-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | trimethoprim-sulfamethoxazole | Unknown | 960 mg | Oral |